Tirzepatide is a 39-amino-acid peptide with a C20 fatty diacid chain
While Mounjaro itself is currently only FDA-approved to help control blood sugar levels, the active ingredient in the medication, tirzepatide, has been approved for weight loss under a different name
However, type 2 diabetes itself is strongly associated with sexual dysfunction, so any concerns should be discussed with your GP to determine the underlying cause
Its utility as a backbone therapy, with a broad range of risk reduction and treatment benefits may erode the market potential of newer, indication-specific therapies, even in areas where semaglutide is not yet explicitly approved, but initial trial readouts show promising results, e.g
On average, individuals may lose between 4 to 8 pounds within the first month of treatment
Australia follows through access needs across distant communities